Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review

Abstract Background Glioma is still one of the most aggressive and common types of brain and central nervous system cancer, with few effective treatment options. Despite progress in therapy, there is a requirement for new methods to enhance patient outcomes. Doxorubicin (DOX), a type of anthracyclin...

Full description

Bibliographic Details
Published in:European Journal of Medical Research
Main Authors: Elyar Mahboubi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani, Elham Ghasemi
Format: Article
Language:English
Published: BMC 2025-05-01
Subjects:
Glioma
Doxorubicin
Overall survival
Progression-free survival
Online Access:https://doi.org/10.1186/s40001-025-02674-5

Internet

https://doi.org/10.1186/s40001-025-02674-5

Similar Items